Separating EPO's Repair Signal from Its Blood Effect

Erythropoietin has two distinct effects: stimulating red blood cell production (hematopoietic) and protecting tissues from injury (tissue-protective). The tissue-protective effect is mediated by the innate repair receptor, a heteromer of the EPO receptor and CD131.

ARA-290 (cibinetide) is a short peptide from EPO's helix B domain designed to activate this repair receptor without triggering erythropoiesis. This is why it can be studied in conditions like small-fiber neuropathy at doses that do not dangerously raise hematocrit. This thread explores the receptor biology and the clinical research landscape.